Skip to main content
Back to OrbiMed

OrbiMed's Genetics Portfolio

Browse 8 Genetics companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Genetics Companies
8
Total Funding in Genetics
$599.4M

Genetics Portfolio Companies (8)

Export
BiopharmaBiotechnologyGeneticsMedicalPharmaceuticalTherapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Dallas, United States
September 2025
$29.4M
Debt Financing

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Cambridge, United States
July 2021
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Cambridge, United States
April 2026
$180.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyGenetics

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

Philadelphia, United States
November 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsTherapeuticsVeterinary

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

Philadelphia, United States
October 2021
$33.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGenetics

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.

Foster City, United States
January 2021
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio